
3B Blackbio DX Ltd is Rated Sell
2026-08-03 10:10:443B Blackbio DX Ltd is rated Sell by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 August 2026, providing investors with the latest insights into its performance and outlook.
Read full news article
3B Blackbio DX Ltd is Rated Sell
2026-07-23 10:10:523B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-14 08:02:013B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent day gain of 4.93%, the company’s technical indicators reveal a cautious outlook, with the MarketsMOJO Mojo Grade downgraded from Hold to Sell as of 23 Mar 2026.
Read full news article
3B Blackbio DX Ltd is Rated Sell
2026-07-12 10:10:133B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-07-08 08:02:083B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish outlook. The company’s MarketsMOJO grade was downgraded from Hold to Sell on 23 March 2026, reflecting deteriorating technical and price action trends amid a challenging market environment.
Read full news article
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-07-02 08:03:183B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has exhibited a nuanced shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals. Despite a recent upgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators reveal a landscape of cautious optimism tempered by underlying weaknesses.
Read full news article
3B Blackbio DX Ltd is Rated Sell
2026-07-01 10:10:223B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 July 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
3B Blackbio DX Ltd is Rated Sell by MarketsMOJO
2026-06-20 10:10:163B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trend, and technical outlook.
Read full news article
3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-06-18 08:01:453B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, prompting a downgrade in its Mojo Grade from Hold to Sell as of 23 March 2026. The stock’s recent price action and technical indicators suggest increasing bearish pressure, with the share price declining by 4.8% on 18 June 2026 to ₹1,204.05 from the previous close of ₹1,264.80.
Read full news articleCorporate Actions
No Upcoming Board Meetings
3B Blackbio DX Ltd has declared 40% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available






